caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1861706525

Michael GelfandMD

NeurologyPhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$14K
Payment records
9
By payment type
Consulting Fee$14K
Food and Beverage$346
PRESCRIBING · PART D · 2024
Total Rx claims
1,525
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
25
Brand share
41.7%
Top prescribed drugs
Lamotrigine178 claims
Clobazam174 claims
Lamotrigine143 claims
Levetiracetam136 claims
Lacosamide122 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
312
Unique beneficiaries
—
Total services
360
Distinct HCPCS
7
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 850 Neurology providers in PA — above median (cohort median 399).